CATALOGO DEI PRODOTTI DELLA RICERCA

GATTI, Davide
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 16.176
EU - Europa 16.109
AS - Asia 11.622
SA - Sud America 1.620
AF - Africa 331
OC - Oceania 25
Continente sconosciuto - Info sul continente non disponibili 12
Totale 45.895
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 15.909
RU - Federazione Russa 5.603
SG - Singapore 4.822
GB - Regno Unito 4.052
CN - Cina 3.409
IT - Italia 1.609
BR - Brasile 1.296
DE - Germania 1.054
HK - Hong Kong 995
VN - Vietnam 917
SE - Svezia 866
FR - Francia 853
IE - Irlanda 749
FI - Finlandia 608
KR - Corea 380
IN - India 222
UA - Ucraina 218
JP - Giappone 174
TR - Turchia 157
CA - Canada 129
AR - Argentina 114
BD - Bangladesh 105
NL - Olanda 94
MX - Messico 92
NG - Nigeria 88
IQ - Iraq 78
ID - Indonesia 76
PL - Polonia 75
ZA - Sudafrica 71
ES - Italia 60
EC - Ecuador 52
BE - Belgio 49
CO - Colombia 41
PK - Pakistan 39
AT - Austria 38
UZ - Uzbekistan 36
CL - Cile 34
VE - Venezuela 29
TG - Togo 28
RO - Romania 26
SA - Arabia Saudita 25
BJ - Benin 23
EG - Egitto 23
IR - Iran 22
MA - Marocco 21
LT - Lituania 20
PE - Perù 20
KE - Kenya 19
AU - Australia 17
CH - Svizzera 17
PH - Filippine 17
CZ - Repubblica Ceca 16
PY - Paraguay 14
IL - Israele 13
AE - Emirati Arabi Uniti 12
DZ - Algeria 12
JO - Giordania 12
MY - Malesia 12
PT - Portogallo 12
AZ - Azerbaigian 11
NP - Nepal 11
TN - Tunisia 11
AL - Albania 9
BO - Bolivia 9
ET - Etiopia 9
HR - Croazia 9
SK - Slovacchia (Repubblica Slovacca) 9
BG - Bulgaria 8
DO - Repubblica Dominicana 8
LB - Libano 8
QA - Qatar 8
A2 - ???statistics.table.value.countryCode.A2??? 7
CR - Costa Rica 7
GE - Georgia 7
GR - Grecia 7
NZ - Nuova Zelanda 7
PA - Panama 7
RS - Serbia 7
UY - Uruguay 7
AM - Armenia 6
DK - Danimarca 6
PS - Palestinian Territory 6
SN - Senegal 6
JM - Giamaica 5
KW - Kuwait 5
LV - Lettonia 5
NO - Norvegia 5
SY - Repubblica araba siriana 5
BY - Bielorussia 4
KG - Kirghizistan 4
KZ - Kazakistan 4
SV - El Salvador 4
TH - Thailandia 4
BW - Botswana 3
EE - Estonia 3
GT - Guatemala 3
HU - Ungheria 3
MK - Macedonia 3
OM - Oman 3
SI - Slovenia 3
Totale 45.830
Salva come PNG Salva come JPEG
Città #
Southend 3.616
Singapore 2.554
Moscow 1.830
Ashburn 1.829
Chandler 1.642
Jacksonville 1.488
San Jose 1.461
Dallas 1.374
Hong Kong 968
Woodbridge 787
Dublin 740
Ann Arbor 645
Verona 559
Beijing 523
The Dalles 498
Houston 485
New York 328
Wilmington 311
Princeton 304
Lawrence 303
Los Angeles 297
Ho Chi Minh City 292
Jinan 254
Nanjing 217
Shenyang 206
Hanoi 201
Bologna 194
Redmond 190
Helsinki 161
Tokyo 159
Buffalo 158
Munich 140
Tianjin 135
Hebei 133
Sindelfingen 123
Milan 113
Redondo Beach 107
São Paulo 106
Santa Clara 98
Columbus 95
Changsha 93
Abuja 86
Zhengzhou 86
Haikou 85
Ningbo 85
Nanchang 82
Orem 73
Hangzhou 72
Taizhou 72
Boardman 71
San Francisco 70
Guangzhou 69
London 65
Warsaw 65
Jiaxing 64
Taiyuan 61
Denver 59
Falkenstein 57
Turku 57
Seattle 56
Council Bluffs 55
Chicago 50
Da Nang 48
Rome 48
Brussels 46
Montreal 46
Hyderabad 45
Redwood City 45
Frankfurt am Main 44
Phoenix 44
Washington 44
Atlanta 43
Norwalk 43
Brooklyn 41
Rio de Janeiro 41
Falls Church 40
Johannesburg 38
Fairfield 37
Jakarta 36
Brasília 35
Toronto 35
Boston 34
Tashkent 34
Fuzhou 33
Lanzhou 33
Stockholm 33
Chennai 32
Mexico City 32
Belo Horizonte 31
Poplar 31
Detroit 30
Düsseldorf 30
Manchester 30
Biên Hòa 29
Haiphong 28
Lomé 28
Seoul 28
Amsterdam 27
Dearborn 26
Lancaster 26
Totale 28.531
Salva come PNG Salva come JPEG
Nome #
Teriparatide and denosumab combination therapy and skeletal metabolism 340
[The long term correction of vitamin D deficiency: comparison between different treatments with vitamin D in clinical practice.]. 265
A case of adult chronic recurrent multifocal osteomyelitis successfully treated with neridronate 264
Acute Phase Response After Zoledronic Acid is Associated with Long-Term Effects on White Blood Cells. 259
Long-term effects of amino-bisphosphonates on circulating gamma-delta T cells 251
CD14(++) CD16(-) monocytes are the main source of 11β-HSD type 1 after IL-4 stimulation 251
25-hydroxyvitamin D levels in healthy premenopausal wome: association with bone turnover markers and bone mineral density 241
The effects of menopause and estrogen replacement therapy on the renal handling of calcium 239
Anti-CCP antibodies and bone 239
Association of CTR and COLIA1 alleles with BMD values in peri and postmenopausal women 237
[Therapeutic strategies in osteoporosis: whom and when to treat] 229
La correzione dell’ipovitaminosi D nel lungo termine: confronto tra diverse modalità di somministrazione di vitamina D nella pratica clinica. 227
Bone mineral density, bone turnover markers and fractures in patients with indolent systemic mastocytosis 224
Changes in Dkk-1, sclerostin, and RANKL serum levels following discontinuation of long-term denosumab treatment in postmenopausal women 221
Type VI Osteogenesis imperfecta: effect of plasma transfusion on bone metabolism 219
Bone Metabolism in a Large Cohort of Patients with Systemic Sclerosis 218
Bone metabolism in patients with anorexia nervosa and amenorrhoea 218
[Risk factors for hip fracture in elderly persons]. 214
Prevalence, pathogenesis, and treatment options for mastocytosis-related osteoporosis 212
AB0776 18F-Fluoride PET/CT for Detection of Axial Involvement in Ankylosing Spondylitis: 210
Bisphosphonate treatment of postmenopausal osteoporosis is associated with a dose dependent increase in serum sclerostin. 209
Hajdu Cheney Syndrome; report of a novel NOTCH2 mutation and treatment with denosumab 209
Bone mineral density and bone turnover in premenopausal women with rheumatoid arthritis 206
Challenge of diagnosing ANCA-associated vasculitis during COVID-19 pandemic: a missed 'window of opportunity' 206
Longitudinal Evaluation of Bone Mineral Density and Bone Metabolism Markers in Patients with Indolent Systemic Mastocytosis Without Osteoporosis 205
Association between non-alcoholic fatty liver disease and bone turnover biomarkers in post-menopausal women with type 2 diabetes 205
A case of mandible Paget’s disease of the bone treated with intravenous neridronate 204
Clinical profile and outcome of patients with rheumatoid arthritis and abnormally high aortic stiffness 202
Amino-Bisphosphonates and Cardiovascular Risk: A New Hypothesis Involving the Effects on Gamma-Delta T Cells 201
Is vitamin D deficiency a risk factor for osteonecrosis of the jaw in patients with cancer? A matched case-control study. 201
Bone involvement and osteoporosis in mastocytosis. 200
Parathyroid hormone is a determinant of serum Dickkopf-1 levels in ankylosing spondylitis 200
Bisphosphonates vs infliximab in ankylosing spondylitis treatment. 197
18F-fluoride PET/CT for detection of axial involvement in ankylosing spondylitis: correlation with disease activity 196
Concentric left ventricular remodelling is associated with subclinical systolic dysfunction in patients with psoriatic arthritis 194
Comment on: clinical efficacy of oral alendronate in ankylosing spondylitis: a randomised placebo-controlled trial 191
Treatment with neridronate in children and adolescents with osteogenesis imperfecta: Data from open-label, not controlled, three-year Italian study 188
Prevalence and incidence of rheumatoid arthritis in Italy. 187
Circulating Dickkopf-1 and sclerostin in patients with Paget's disease of bone 187
Acute Effects of Glucocorticoid Treatment, TNFα or IL-6R Blockade on Bone Turnover Markers and Wnt Inhibitors in Early Rheumatoid Arthritis: A Pilot Study 187
Teriparatide Treatment in Adult Patients with Osteogenesis Imperfecta Type I. 186
Could γ\δ T-cells explain zoledronic acid adverse events? 186
Combined Circumferential and Longitudinal Left Ventricular Systolic Dysfunction in Patients with Rheumatoid Arthritis without Overt Cardiac Disease 184
New strategies for the prevention and treatment of systemic and local bone loss; from pathophysiology to clinical application 184
Association between bone mineral density and serum lipid in men 183
Effects of TNF Inhibitors on Parathyroid Hormone and Wnt Signaling Antagonists in Rheumatoid Arthritis 183
Duration of the effects of intravenous alendronate in postmenopausal women and in patients with primary hyperparathyroidism and Paget's disease of bone 182
Serum Levels of Tryptase Suggest That Mast Cells Might Have an Antiinflammatory Role in Rheumatoid Arthritis: Comment on the Article by Rivellese et al 181
Association Between Short-term Exposure to Environmental Air Pollution and Psoriasis Flare 181
[Antinflammatory therapy and cardiovascular risk: a consensus view]. 180
Correction to: Is the exposure to bisphosphonates or osteoporosis the predictor of spinal radiographic progression in ankylosing spondylitis? 179
Allergy and the bone: unexpected relationships 176
An exploratory study on the role of vitamin D supplementation in improving pain and disease activity in rheumatoid arthritis 176
Prednisone compared to methysprednisolone in the polymyalgia rheumatica treatment 175
[Use of nonsteroidal anti-inflammatory drugs in patients with vertebral osteoporotic fractures]. 175
Guidelines for the diagnosis, prevention and management of osteoporosis 175
Denosumab for the Treatment of Mastocytosis-Related Osteoporosis: A Case Series 174
Rapporti tra sistema immune e metabolismo osseo 172
Osteoporosis treatment: why ibandronic acid? 172
Higher Level of Dickkopf-1 is Associated with Low Bone Mineral Density and Higher Prevalence of Vertebral Fractures in Patients with Ankylosing Spondylitis 171
Clinical utility of a wheat-germ precipitation assay for determination of bone alkaline phosphatase concentrations in patients with different metabolic bone diseases 170
Prevalence and incidence of osteoporotic fractures in patients on long-term glucocorticoid treatment for rheumatic diseases: the Glucocorticoid Induced OsTeoporosis TOol (GIOTTO) study 170
Distinct effect of zoledronate and clodronate on circulating levels of DKK1 and sclerostin in women with postmenopausal osteoporosis. 169
Cancer in adult patients with inflammatory arthritis is associated with high ascending aortic stiffness and left ventricular hypertrophy and diastolic dysfunction 169
Osteoporosis and fractures in systemic vasculitides: a systematic review and meta-analysis 166
DXA bone mineral density in males: retrospective study in real life. 166
Calcio e derivati della vitamina D, terapia sostitutiva, calcitonina, fluoruri, bisfosfonati 166
Effects of biological and targeted synthetic DMARDs on bone loss in rheumatoid arthritis 166
Sclerostin and DKK1 in postmenopausal osteoporosis treated with Denosumab. 165
Association between long-term exposure to air pollution and immune-mediated diseases: a population-based cohort study 165
Dickkopf-1 and sclerostin serum levels in patients with systemic mastocytosis 164
In psoriatic arthritis Dkk-1 and PTH are lower than in rheumatoid arthritis and healthy controls 164
Dose-dependent short-term effects of single high doses of oral vitamin D3 on bone turnover markers 163
Correspondence on 'Characteristics associated with hospitalisation for COVID-19 in people with rheumatic disease: data from the COVID-19 Global Rheumatology Alliance physician-reported registry' by Gianfrancesco et al. Disease activity, rather than glucocorticoid therapy, may be associated with COVID-19 severity in patients with rheumatic musculoskeletal diseases 162
Effect of hyperandrogenism and menstrual cycle abnormalities on bone mass and bone turnover in young women 161
Clinical profile and outcome of patients with chronic inflammatory arthritis and metabolic syndrome 160
Effects of denosumab on peripheral lymphocyte subpopulations 160
Artropatie degenerative 159
Sclerostin and DKK1 in primary hyperparathyroidism. 159
Rituximab increases peripheral natural killer cells in patients with rheumatoid arthritis 158
Bone health, an often forgotten comorbidity in systemic lupus erythematosus: a comment on the new recommendations 158
Association between acute exposure to environmental air pollution and fragility hip fractures 157
Effects of intra-articular clodronate in the treatment of knee osteoarthritis: results of a double-blind, randomized placebo-controlled trial 157
GH in combination with bisphosphonate treatment in osteogenesis imperfecta 157
Coxibs: a significant therapeutic opportunity. 156
Prevalence of osteoporosis in patients affected by mastocytosis 156
Safety issues and adverse reactions with osteoporosis management 156
Association between environmental air pollution and rheumatoid arthritis flares 156
Diffuse idiopathic skeletal hyperostosis (DISH) in type 2 diabetes: a new imaging possibility and a new biomarker 155
Association between increased carotid intima-media thickness and higher serum C-terminal telopeptide of type 1 collagen levels in post-menopausal women with type 2 diabetes 155
Association Between Nonalcoholic Fatty Liver Disease and Reduced Bone Mineral Density in Children: A Meta-Analysis 154
Hypophosphatasia in adults: A new manifestation, a new mutation. A case report 154
Factors associated with referral for osteoporosis care in men: a real-life study of a nationwide dataset 154
Insulin-like growth factor-1 is associated with bone formation markers, PTH and bone mineral density in healthy premenopausal women. 152
Improvements in the management of rheumatic patients from vertebral imagee obtained through dual-energy X-ray absorptiometry. 151
Denosumab, cortical bone and bone erosions in rheumatoid arthritis 151
In patients with rheumatoid arthritis, Dickkopf-1 serum levels are correlated with parathyroid hormone, bone erosions and bone mineral density 151
Osteoporosis: an Independent Determinant of Bone Erosions in Rheumatoid Arthritis? 150
Periostin: The bone and beyond 150
Long-term Effects of Neridronate in Adults with Osteogenesis Imperfecta: An Observational Three-Year Italian Study 149
Totale 18.689
Salva come PNG Salva come JPEG
Categoria #
all - tutte 153.694
article - articoli 149.123
book - libri 0
conference - conferenze 646
curatela - curatele 0
other - altro 246
patent - brevetti 0
selected - selezionate 0
volume - volumi 3.679
Totale 307.388
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/2021374 0 0 0 0 0 0 0 0 0 18 259 97
2021/20222.363 195 608 27 111 119 113 37 130 169 65 196 593
2022/20234.908 372 430 477 889 434 1.180 55 262 535 46 167 61
2023/20242.537 106 207 229 306 306 415 111 184 43 100 364 166
2024/20256.683 358 448 296 1.026 347 198 306 298 999 579 533 1.295
2025/202618.317 1.371 996 1.473 3.206 4.687 1.298 1.925 1.103 1.369 889 0 0
Totale 46.443